Sign In
Buy LIVN
$71.33
-2.00 (-2.73%)
At Close: Jun 03, 2026
A Look At LivaNova's (NASDAQ:LIVN) CEO Remuneration
06:47pm, Wednesday, 29'th Jul 2020
Damien McDonald became the CEO of LivaNova PLC (NASDAQ:LIVN) in 2017, and we think it's a good time to look at the...
LivaNova (LIVN) Reports Q2 Loss, Tops Revenue Estimates
11:30am, Wednesday, 29'th Jul 2020
LivaNova (LIVN) delivered earnings and revenue surprises of 50.00% and 6.10%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
LivaNova: Q2 Earnings Insights
11:17am, Wednesday, 29'th Jul 2020
Shares of LivaNova (NASDAQ:LIVN) were unchanged after the company reported Q2 results.Quarterly Results Earnings per share were down 121.43% year over year to ($0.15), which beat the estimate of ($0.3
LivaNova PLC 2020 Q2 - Results - Earnings Call Presentation
09:32am, Wednesday, 29'th Jul 2020
The following slide deck was published by LivaNova PLC in conjunction with their 2020 Q2 earnings call.
LivaNova Reports Second Quarter 2020 Results
09:00am, Wednesday, 29'th Jul 2020
LivaNova PLC, a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2020.
Analysts Estimate LivaNova (LIVN) to Report a Decline in Earnings: What to Look Out for
04:33pm, Wednesday, 22'nd Jul 2020
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Did Hedge Funds Make The Right Call On LivaNova PLC (LIVN) ?
10:38pm, Monday, 20'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
LivaNova Announces Commercial Launch of Perceval Plus Aortic Heart Valve in Europe
01:00pm, Thursday, 16'th Jul 2020
LivaNova PLC today announced the advanced Perceval® Plus sutureless surgical aortic heart valve is now available for commercial release in Europe.
LivaNova announced a publication in Contemporary Clinical Trials about the RECOVER study design for VNS Therapy for treatment-resistant depression.
LivaNova to Host Conference Call for Second Quarter 2020 Results
01:00pm, Monday, 29'th Jun 2020
LivaNova PLC will host a conference call to discuss its second quarter 2020 results on Wednesday, July 29, 2020 at 12 p.m. London time (7 a.m. EDT).
Hedge Funds Are Getting Bullish On LivaNova PLC (LIVN)
07:09pm, Monday, 15'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
LivaNova Announces Pricing of Private Offering of $250 Million of 3.00% Cash Exchangeable Senior Notes Due 2025
12:30pm, Friday, 12'th Jun 2020
LivaNova PLC today announced the pricing of $250 million aggregate principal amount of 3.00% cash exchangeable senior notes due 2025.
LivaNova Announces Proposed Private Offering of $250 Million of Cash Exchangeable Senior Notes
10:55am, Thursday, 11'th Jun 2020
LivaNova PLC announced its intention to offer $250 million aggregate principal amount of cash exchangeable senior notes due 2025 in private offering.
LivaNova Announces New Senior Secured Credit Facility
10:52am, Thursday, 11'th Jun 2020
LivaNova PLC today announced its entry into a five-year $450m senior secured credit facility with funds managed by affiliates of Ares Management Corp.
Here’s Why LivaNova (LIVN) Stock is an Attractive Pick for Investors
02:09pm, Monday, 08'th Jun 2020
Diamond Hill Capital recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Diamond Hill Small Cap Fund posted a return of -36.17% for the quarter, underperforming
